Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
40.23
+1.21 (3.10%)
Sep 5, 2025, 2:45 PM CST
SHE:002422 Revenue
Sichuan Kelun Pharmaceutical had revenue of 4.69B CNY in the quarter ending June 30, 2025, a decrease of -16.30%. This brings the company's revenue in the last twelve months to 19.07B, down -15.18% year-over-year. In the year 2024, Sichuan Kelun Pharmaceutical had annual revenue of 21.81B with 1.67% growth.
Revenue (ttm)
19.07B
Revenue Growth
-15.18%
P/S Ratio
3.37
Revenue / Employee
872.15K
Employees
21,864
Market Cap
64.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21.81B | 358.49M | 1.67% |
Dec 31, 2023 | 21.45B | 2.42B | 12.69% |
Jan 1, 2023 | 19.04B | 1.76B | 10.19% |
Jan 1, 2022 | 17.28B | 813.21M | 4.94% |
Dec 31, 2020 | 16.46B | -1.17B | -6.65% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |